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Monitoring blood potassium 
concentration in hemodialysis 
patients by quantifying T‑wave 
morphology dynamics
Flavio Palmieri1,2,3*, Pedro Gomis1,4, Dina Ferreira3, José Esteban Ruiz5, Beatriz Bergasa5, 
Alba Martín‑Yebra2,6, Hassaan A. Bukhari2,6, Esther Pueyo2,6, Juan Pablo Martínez2,6, 
Julia Ramírez7 & Pablo Laguna2,6
We investigated the ability of time‑warping‑based ECG‑derived markers of T‑wave morphology 
changes in time ( d
w
 ) and amplitude ( d
a




 ), and 
the heart rate corrected counterpart ( d
w,c ), to monitor potassium concentration ( [K+] ) changes 
( [K+] ) in end‑stage renal disease (ESRD) patients undergoing hemodialysis (HD). We compared the 
performance of the proposed time‑warping markers, together with other previously proposed [K+] 
markers, such as T‑wave width ( T
w
 ) and T‑wave slope‑to‑amplitude ratio ( T
S/A ), when computed from 
standard ECG leads as well as from principal component analysis (PCA)‑based leads. 48‑hour ECG 










w,c were calculated by comparing the morphology of the mean warped 
T‑waves (MWTWs) derived at each hour along the HD with that from a reference MWTW, measured 
at the end of the HD. From the same MWTWs T
w
 and T
S/A were also extracted. Similarly, [K+] was 
calculated as the difference between the [K+] values at each hour and the [K+] reference level at 
the end of the HD session. We found that d
w
 and d
w,c showed higher correlation coefficients with 
[K+] than T
S/A—Spearman’s ( ρ ) and Pearson’s (r)—and Tw—Spearman’s ( ρ)—in both SL and PCA 
approaches being the intra‑patient median ρ ≥ 0.82 and r ≥ 0.87 in SL and ρ ≥ 0.82 and r ≥ 0.89 in 
PCA respectively. Our findings would point at d
w
 and d
w,c as the most suitable surrogate of [K+] , 
suggesting that they could be potentially useful for non‑invasive monitoring of ESRD‑HD patients in 
hospital, as well as in ambulatory settings. Therefore, the tracking of T‑wave morphology variations by 
means of time‑warping analysis could improve continuous and remote [K+] monitoring of ESRD‑HD 
patients and flagging risk of [K+]‑related cardiovascular events.
Chronic kidney disease (CKD) is defined as the presence of kidney damage, persisting for 3 months or more, 
irrespective of the  cause1. It represents a state of progressive loss of kidney function ultimately resulting in need 
for renal replacement therapy such as hemodialysis (HD) or transplantation. The development of CKD and its 
progression to this terminal stage, called end-stage renal disease (ESRD), remains a significant source of reduced 
quality of life and premature  mortality2. In particular, sudden cardiac death (SCD) represents an important cause 
of death in ESRD-HD  patients3. Various risk factors may be responsible for SCD in this patient population, 
including left ventricular hypertrophy and fibrosis, disordered bone-mineral metabolism, HD-induced changes 
in electrolyte, and fluid and acid-base status, which may lead to electrocardiographic (ECG) abnormalities and 
ventricular  arrhythmia3,4.
Recent studies have shown that blood potassium concentrations ( [K+] ) outside the physiological interval are 
associated with increased mortality  risk5. In healthy conditions, the maintenance of [K+] homeostasis is ensured 
by normal renal  activity6. However, ESRD-HD patients suffer from [K+] imbalance, leading to a high incidence 
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of arrhythmic events. The pro-arrhythmic consequences of [K+] imbalance can be explained considering that 
potassium currents are involved in the repolarization process of the cardiac action potential (AP), determining 
membrane potential and refractoriness of the  myocardium7. Therefore, even modest deviations of [K+] from its 
normal range (hypokalemia if [K+] < 3.5 mmol/L or hyperkalemia if [K+] > 5 mmol/L) may lead to hospitalisa-
tion or death in ESRD-HD  patients8. Evaluation of [K+] levels is currently based on blood samples that require 
further analyses in the laboratory, limiting continuous monitoring. Non-invasive markers able to track variations 
in [K+] levels are therefore needed.
The electrocardiogram (ECG) is a non-invasive, easily accessible, and inexpensive practice that reflects the 
electrical activity of the heart. In particular, the T-wave reflects the spatio-temporal repolarization of the ven-
tricle, and its analysis has been used to measure the vulnerability of a patient to ventricular  arrhythmias9. This 
fact is of particular interest because T waves are frequently altered in ESRD-HD  patients4. The QT interval is the 
standard index of ventricular repolarization, and it has been proposed to monitor ESRD-HD  patients10. However, 
the effects of HD on QT interval, and its corrected version QTc, are still controversial, since several  studies11 
reported a prolongation during the HD sessions, but others reported opposite trend or even no changes at  all12. 
This motivates the analysis of the overall T-wave morphology as a potential potassium level marker.
Different T-wave morphology markers have been previously reported to be correlated with [K+] , such as the 
T-wave right  slope13, the width of the T-wave ( Tw)14, the T-wave slope-to-amplitude ratio ( TS/A)15, and a mor-
phology combination score, which integrates features like T-wave asymmetry, flatness and  notching16. However, 
these markers rely on specific local features of the T-wave rather than in the overall T-wave morphology, which 
may have a stronger potential in following [K+] than indices based on local features.
A recent study reported a time-warping based methodology to quantify changes in the overall T-wave 
 morphology17. Six indices were proposed, duw and da , reflecting morphological variations in time and amplitude, 
respectively, as well as their non-linear version, dNLw  and dNLa  as reported  in17 and two novel markers derived from 
duw and named dw and dw,c . The main goal of this study is to investigate the potential of these markers in moni-
toring both hypo- and hyperkalemia events excluding the variability due to the heart rate (HR) and to compare 
their performance against Tw and TS/A in standard single-lead approach and by applying principal component 
analysis (PCA) as multilead space reduction technique. However, some of the above mentioned indices may not 
be robust enough for our purpose. It is the case of dw which does not provide information about the direction 
of the T-wave morphological variation (i.e. if there is stretching or shortening) and has been found to be cor-
related with HR. Therefore, we have adapted the original  methodology17 to account for hypo- and hyperkalemia, 
and we propose a new marker that is independent of HR, thus offering a more precise [K+] monitoring tool 
for arrhythmic risk stratification in ESRD-HD patients. Preliminary results extracted from a smaller subset of 
patients have been presented at Computing in Cardiology  conference18,19 while the electrophysiological basis 
was studied in Bukhari et al.20.
The novelties of the present study with respect to the state-of-the-art are: (1) the usage of T-wave time warp-
ing analysis for non-invasive [K+] monitoring, together with the development of a HR correction tool for the 
time-warping marker, dw,c ; (2) the proposal of a PCA spatial transformation lead for marker extraction and (3) 
the validation of the proposed markers in comparison with previously published biomarkers ( Tw and TS/A ) and 
with their extraction from standard leads.
Materials and methods
Study population. The study population included 29 patients from the Nephrology ward from Hospital 
Clínico Universitario Lozano Blesa (Zaragoza, Spain). Inclusion criteria were (i) 18-year-old (or older), (ii) hav-
ing a diagnosed ESRD pathology and (iii) undergoing HD at least three times per week (with venous or cannula 
access). Table 1 shows the population characteristics. The study protocol was approved by the Aragon’s research 
ethics committee (CEICA, ref. PI18/003) and all patients and/or their legal guardians signed informed consent. 
All the procedures and all the methods were performed in accordance with the Helsinki Declaration. The data-
base collection is still ongoing, with the current size significant enough for a pilot  study21,22. 
Data collection. General information. Sex, age, concomitant therapies (e.g. assumption of anti-arrhyth-
mic drugs), kidney disease etiology and HD treatment related information were collected for each enrolled 
patient, as detailed in Table 1.
Blood sample analysis. For each patient, six blood samples were taken and analysed during the HD session: the 
first one at the HD onset and the next three, every subsequent hour (Fig. 1, h0 to h3 in red). The 5-th blood sam-
ple was collected at the end of the HD (minute 215-th or 245-th, depending on the HD session duration) while 
the 6-th blood sample was taken after 48 h, immediately before the next HD session. Potassium, magnesium, 
calcium, urea, creatinine, bicarbonate and pH were measured from each blood test. Blood potassium concentra-
tions values for each blood test are given in Table 2.
ECG measurements. A 48h, standard 12-lead ECG Holter recording, (H12+, Mortara Instruments, Milwaukee, 
WI, USA, sampling frequency of 1 kHz, amplitude resolution of 3.75 µV), was obtained for each enrolled patient, 
starting the acquisition 5 min before the HD onset (Fig. 1, blue line). The block diagram presented in Fig. 2a 
describes the main steps of the whole data processing implemented in this work.
ECG pre‑processing. ECG filtering. Holter ECG signals contain baseline drift and other noises, such as 
power-line and muscular activity (Fig. 2a). Therefore, an initial pre-processing is needed to improve the signal-
3
Vol.:(0123456789)
Scientific Reports |         (2021) 11:3883  | https://doi.org/10.1038/s41598-021-82935-5
www.nature.com/scientificreports/
to-noise ratio (SNR) and enable ECG waveform analysis. First, baseline wander was removed with a high-pass, 
forward-backward 6-th order Butterworth filter with 0.5 Hz cut-off  frequency23 (Fig. 2a). Then, residual noise 
out of the T-wave band was removed with a 6-th order low-pass Butterworth filter with 40 Hz cut-off frequency.
ECG waveform detection and delineation. A wavelet-based single-lead  method24 was applied to detect QRS 
complexes and then delineate T-wave onsets and ends in each of the 12 leads. The wavelet transform (WT) 
decomposes the signal in the time-scale domain, allowing its representation at different resolutions. It is, there-
fore, a suitable tool to analyze ECG signals, which contain patterns with different frequency content (QRS com-
plexes, P and T-waves).
Single‑lead delineation. The discrete dyadic WT is implemented in such a way that it keeps temporal resolution 
at different scales. The detection of the fiducial points is carried out across the adequate WT scales, attending 
to the dominant frequency components of each ECG wave: Q,R,S waves correspond to a simultaneous effect in 
scales 21–22 , while the T and P waves affect mainly scales 24 or 25 ,  see24 for details. ECG wave peaks correspond 
to zero crossings in the WT, and ECG maximum slopes correspond to WT’s maxima and minima. Depending 
on the number and polarity of the slopes found, a wave morphology is assigned and boundaries are located using 
threshold-based criteria. The onset (end) of a wave occurs before (after) the first (last) significant slope associ-
ated with the  wave24.
Selection rules for multi‑lead delineation. To obtain multilead peak locations, a median post-processing selec-
tion rule over the single-lead-based detected locations is used. The post-processing rules for boundaries consist 
of ordering the single-lead annotations and selecting as the onset (end) of a wave the first (last) annotation 
whose k nearest neighbours lay within a δ ms  interval24,25.
Single‑lead analysis. First, we performed the analysis using the single-lead ECG, taking the T-waves from leads 
V3 to V6, as used in a previous  study26 for [K+] estimation, and lead II being the most widely used in patient 
 monitoring27. These T waves were further delineated by using the above motioned  delineator24 and the bio-
marker estimation is performed as described below in section named “Time warping analysis”.
Spatial lead reduction by principal component analysis. Next, a spatial lead reduction by Principal Component 
Analysis (PCA) was made since it was found to be a robust spatial transformation to emphasize waveform  SNR28. 
In this work PCA was spatially applied to the 8 independent leads, learned over the T-wave segment to mainly 
emphasize this waveform, and resulting in 8 principal components (PCs) or transformed leads. The coefficients 
defining the PCA transformation were obtained from the eigenvectors of the 8× 8 interlead auto-correlation 
matrix computed over the T-waves in a 10-min wide window at the end of the HD session. The correct deline-
ation of T-waves is crucial to emphasize only T-wave energy content. The first PCA, denoted as PC1, was used 
for the subsequent ECG analysis, as it is the transformed lead where the T-waves have maximal energy, and thus, 
maximal SNR for morphological  characterisation28,29. PC1 was further delineated by applying  again24, and each 
T-wave was further low-pass filtered at 20 Hz using a 12-th order Butterworth filter to restrict shape analysis to 
the dominant band of the T-wave so removing remaining noisy components that could still corrupt the T-wave 
shape analysis.
Time‑warping analysis. Two-minute ECG segments, centred on the 5-th and 35-th minutes of each avail-
able hour, were analysed. The window duration was short enough to hold the assumption of stability for both 
[K+] and HR values. Figure 5a shows the average RR interval for each selected i-th 2-min segments for a given 
patient along the ECG recording. While the blood samples (purple diamonds) were collected each hour during 
the HD, the warping parameters were computed every half an hour to get a more detailed view over time.
For each i-th 2-min segment, a mean warped T-wave (MWTW) was computed. First of all, the predominant 
T-wave polarity (e.g. upward, downward etc) within a given window, was defined as that having the highest 
number of occurrences. This polarity change can be physiological or induced by delineator oscillation when by-
phasic to regular T-waves appears almost indistinguishable. A T-wave was considered to have inverted polarity 
if the magnitude of its peak had negative sign and vice-versa. Only those T-waves having the same polarity as 
ECG acquisition





ℎ1ℎ0 ℎ2 ℎ3 ℎ4 ℎ5
Time (min)
Figure 1.  Diagram of the study protocol: h0 to h5 are the time points (in minutes) for blood sample extraction. 
h4 is taken at the end of the HD (minute 215-th or 245-th, depending on the HD duration).
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Figure 2.  Analysis stages performed in this study. In panel (a) is the flow chart showing the ECG processing 
steps for T-wave time-warping markers extraction. The analysis starts with the original ECG, followed by a 
filtering step before spatial PCA analysis, to conclude with markers computation. Panel (b) shows an example 
of the linear and nonlinear time-warping markers for the same patient as in Fig. 5a. In particular, subpanel (i) 
shows both the reference (blue) and the i-th MWTW (red) while subpanel (ii) shows the warping function (red 
dotted line) that optimally relates the reference and studied MWTWs. Subpanel (iii) shows the MWTWs after 
warping and subpanel (iv) are the normalized reference and warped MWTWs.
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the predominant one were considered in the following steps. Then, all these selected T-waves were aligned with 
respect to their gravity center and used to compute an initial MWTW 17. Finally, all the T-waves were checked to 
find and discard the outliers, defined as having T-wave duration outside the range Tdmi ± 1.5× σdi centered at the 
i-th ensemble T-wave mean, Tdmi , and bounded function of the T-wave duration standard deviation σdi . Among 
the remaining, only those T-waves highly correlated (Pearson’s correlation coefficient > 0.98) with the previous 
initial MWTW were used to recalculate the final MWTW. The MWTW at the end of the HD treatment was taken 
as the reference, given that it is the time when the patient (a) is supposed to have recovered the normal [K+] level 
and (b) was discharged from hospital, being an appropriate reference for out-of-hospital ambulatory monitoring.
Since hyperkalemia has been reported to cause T-wave  inversions30, any MWTWs with negative-polarity 
was inverted before performing the warping with the reference MWTW. Previous to warping, the two MWTWs 
were aligned with respect to their gravity center, so that only changes in the T-wave morphology, and not those 
associated with their relative delay, were quantified by the warping algorithm.
For comparison purposes, both Tw14 and TS/A15 were extracted from each MWTW and their performance, 
with respect to T-wave time-warping based biomarkers in monitoring [K+] , was assessed. This work perform 
a clinical study following previous analysis testing the marker by electrophysiological simulations as reported 
in Bukhari et al.20.
Table 1.  Characteristics of the study population. Values are expressed as number ( % ) for categorical variables, 
and median (IQR) for continuous variables.
(N = 29)
Age (years) 75 (12)
Gender (male) 20 (70%)
Anti-arrhythmic drugs (yes) 9 (31%)
Implanted pace-maker (yes) 1 (3%)
Time under HD treatment (months) 15 (59)
HD session duration
210 min 3 (10%)
240 min 26 (90%)
Kidney disease etiology
Diabetes mellitus 17 (59%)
Interstitial nephritis 2 (7%)
Glomerulonephritis 2 (7%)
Tuberous sclerosis 1 (3%)




Potassium (1.5 mmol/L) 21 (72%)
Potassium (3 mmol/L) 5 (17%)
Potassium (decreasing) 3 (11%)
Calcium (2.5 mg/dL) 21 (72%)




Acetate-free biofiltration with decreas-
ing intra-HD [K+] 3 (10%)
Table 2.  Blood potassium concentration [K+] values (in mmol/L) at each blood extraction during the HD ( h0 
to h4 ) and HR (beats/min). Spearman’s ( ρ ) and Pearson’s (r) intra-patient correlation coefficients between [K+] 
and RR. Values are expressed as median (IQR).
h0 h1 h2 h3 h4 ρ r
(K+) 5.0 (1.4) 3.8 (1.1) 3.6(0.8) 3.4 (0.7) 3.3 (0.6) 0.10 (1.35) 0.09 (1.45)
HR 81 (28) 76 (28) 80 (23) 80 (17) 80 (25)
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T‑wave time warping. The method here applied was originally proposed by Ramírez et  al.17. Let 
f i(ti) = [f i(ti(1)), . . . , f i(ti(Ni))]
T be the MWTW of a given i-th segment, and f r(tr) = [f r(tr(1), . . . , f r(tr(Nr))]T 
the reference MWTW, where ti = [ti(1), . . . , ti(Ni)]T and tr = [tr(1), . . . , tr(Nr)]T with Ni and Nr being the 
total T-wave duration, in samples, of ti and tr respectively. Figure 2b illustrates the warping method applied 
between one of the i-th MWTW (red) and the reference MWTW (blue). Let γi(tr) be the warping function that 
relates tr and ti , such that the composition (f i ◦ γi)(tr) denotes the re-parametrization or time domain warping 
of f i(ti) using γi(tr) , i.e. (f i ◦ γi)(tr) represents the amplitude values of f i(ti) if its temporal vector was tr . The 
square-root slope function (SRSF) was proposed instead of the original T-waves31,32 to find the optimal warping 
function. This was applied by performing time-warping on the SRSFs of the T-waves, preventing the “pinching 
effect” in cases when T-wave amplitudes  differ33. This transformation is defined as:
The optimal warping function is the one that minimizes the amplitude difference between the SRSF of f r(tr) 
and f i(γi(tr))32:
The dynamic programming algorithm was used to obtain the solution of this optimisation  problem34. Fig-
ure 2b(ii) shows the optimal warping function between the two waves in Fig. 2b(i). The warped T-wave, f i(γ ∗i (tr)) 
is shown in Fig. 2b(iii), together with the reference T-wave, f r(tr).
Time warping biomarkers. The index duw (corresponding to the index denoted as dw  in17), shown as the yellow 
area in Fig. 2b(ii), quantifies the amount of warping needed to optimally align the two T-waves, and is defined as 
the average of the absolute difference value between γ ∗i (tr) and tr:
The original definition of duw(i)17 was modified here to allow the marker to be signed, therefore distinguishing 
T-wave widenings from narrowings. This signed dw(i) was defined as:
where sd(i) was used to account for the sign of the dw(i) and it was computed as:
with Nur  being the set of T-wave up-slope samples. A positive sign means that the f i(ti) has to be widened to fit 
the f r(tr) and vice-versa for a negative sign.
After applying time warping between both MWTWs, the amplitude difference between f r(tr) and f i(γ ∗i (tr)) 





r))− f r(tr)) is used to account for the da(i) sign estimation.
Both dw(i) and da(i) incorporate information from the linear and non-linear differences between both T-waves 
in time and amplitude domain, respectively. The non-linear components can be quantified as  in17:
where γ ∗i,l(t
r) (green line in Fig. 2b(ii)) is the best linear fitting to γ ∗i (tr) according to the least absolute residual 
 criterion35. The parameter dNLw (i) quantifies the non-linear warping by computing the area of the dashed magenta 
region between γ ∗(tr) and γ ∗i,l(t
r) (in Fig. 2b(ii)). Finally, the marker dNLa (i) quantifies the residual information 
in amplitude domain after normalising MWTWs (Fig. 2b(iv)).
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Heart‑rate‑corrected T‑wave warping. It is well known that T-wave duration and QT interval are strongly 
dependent on  HR36. Although aligning the T-waves according to their gravity centre reduces most of the 
dependence of dw(i) on HR, there may still be some residual dependence in T-wave morphology that should be 
compensated for (e.g. see Fig. 5a around hours h = 9, 12 and 43). We assume that dw(i) , as originally proposed 
in (4), can be modelled as the sum of two components:
where dw,HR(i) is the HR dependent component and dw,c(i) is the non-HR dependent component accounting 
for ( K+ ) induced variations and possibly others not HR related.
To estimate the corrected component dw,c(i) we depart from the literature, where several formulae for HR-
dependency correction of repolarization related time intervals, like the QT interval, have been  developed37–40, 
including a variety of approaches (e.g. linear, hyperbolic, exponential models etc.) being investigated and tested 
in view of the complex relationship between QT interval and  HR39. To derive a correction formula and estimate 
dw,c(i) , we started from a linear approximation of a hyperbolic model under small RR changes, derived similarly 
to the QT interval correction (QTc)38,39,
Let’s call RRr the reference RR interval associated to a reference heart beat and RRi the one to the i-th RR interval 
from one beat at the i-th segment, then
As the QTi − QTr difference, also dw(i) is a measure of width change between the reference r and the current i-th 
mean T-waves from their respective observations time windows, then it is possible to extend previous relation 
in (11) to dw(i) obtaining the HR related component
By substituting (12) in (9) we obtain
The value dw,c(i) can be assumed to be non-zero mean, and uncorrelated to HR, that is:
with �dw,c(i) zero mean and uncorrelated to HR. Then, dw(i) becomes:
where the parameters b, β and α , once jointly estimated (i.e. b̂ , β̂ and α̂ ) can be used to derive d̂w,c(i) as:
Note that, β̂ and α̂ cannot be assessed from (15) with a directly least square fitting, since the DC component b in 
(15) largely affects the results. Rather, it is possible to jointly estimate b̂, β̂ and α̂ , and then use the results in (16).
This estimate can be further approximated linearly for small RR changes. Denoting �RR(i) = RRi − RRr , 
RRi can be expressed as RRi = RRr +�RR(i) and by replacing this in the right side of (12):
Operating on the terms and under the assumption that �RR(i) ≪ RRr , (�RR(i)RRr ) ≪ 1 and by using the Taylor’s series expansion, we have
Substituting (18) in (13):
where b, α , β and (RRr)(α−1) are constant values; then placing:
the actual dw(i) dependency with RR will be:
(9)dw(i) = dw,c(i)+ dw,HR(i).
(10)QT = β(RR)α .











































(18)(RRr +�RR(i))α − (RRr)α ≃ α�RR(i)(RRr)(α−1).
(19)dw(i) ≃ b+�dw,c(i)+ α β �RR(i)(RRr)(α−1),
(20)α β(RRr)(α−1) = c,
(21)dw(i) ≃ b+�dw,c(i)+ c �RR(i).
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From the geometrical point of view, b and c can be estimated as the zero-crossing and the slope, respectively, of 
the least-squares line fit to the dw(i) values (in a �RR(i) vs. dw(i) graph). Then, the dw(i) component that does 
not dependent on the RR, meaning it is assumed not correlated, can assessed as:
where ĉ is the estimated slope from the Holter recording, see Fig. 3, d̂w,c(i) is then the corrected estimated of 
dw,c(i) , with RRi and RRr the mean RR interval from the i-th studied segment and the reference windows respec-
tively and ĉ parameter is estimated for every patient during the time course of the Holter recording. When the 
linear approximation presented above cannot be assumed, b̂ , β̂ , and α̂ can be jointly estimated from the model 
in (15), and use the (16) as the corrected estimate.
An example of the estimated d̂w,c(i) is given in Fig. 5a where both d̂w,c(i) and dw(i) where displayed. Notice 
how the proposed correction formula removed the HR-dependency, for example around h = 12.
Table 3 provides an overview of the morphology markers studied in this work.
Potassium concentration variations [K+]. The proposed biomarkers have been compared with the 
relative variations in [K+] (denoted as �[K+](h) ) with respect to a reference [K+] that was taken at the end of 
the HD:
(22)d̂w,c(i) = dw(i)− ĉ �RR(i) = dw(i)− ĉ(RRi − RRr).
Table 3.  T-wave morphology markers for [K+] monitoring. *duw correspond to the marker denoted as dw  in17, 





The reference and the i-th MWTW (ms).
dNLw
Nonlinear component of the
Time-domain changes between
The reference and the i-th MWTW (ms)
da
Relative amplitude changes between
The reference and the i-th MWTW (%)
dNLa
Relative nonlinear amplitude changes
After normalising the reference
And the i-th MWTW (%)
Specifically proposed in this work
dw
Signed version of the
Previously proposed duw * (ms)
dw,c Heart rate corrected version of dw (ms)
(b)(a)
Figure 3.  Scatterplot showing the values of both dw panel (a) and d̂w,c panel (b) with respect to RR for a given 
patient in PCA approach. Spearman’s correlation coefficients ( ρ ) and p-values for both dw and d̂w,c are shown on 
top of each panel, while the least-square fitting regression lines are plotted in red.
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being [K+]h the concentration at the h-th hour during the HD and [K+]r the concentration at the end of the 
treatment. An example of the �[K+](h) evolution is shown in Fig. 5a (purple diamonds).
Statistical analyses. Results are presented as median and interquartile range (IQR). Spearman rank cor-
relation coefficient ( ρ ) and Pearson correlation (r) were used for correlation analysis between [K+] and the 
proposed biomarker, giving information about both the monotonic relation and the strength of the association 
between the time warping based biomarkers and [K+] changes and then providing a more complete characteri-
sation. The average duration of the ECG recordings was 44 h mainly due to electrode detachment or early bat-
tery exhaustion. For this reason, correlation coefficients were computed using the first five values of �[K+](h) 
throughout the HD and the warping markers evaluated at the corresponding i-th segment points ( h = (i − 1)/2 
where i=1, 3, 5, 7, 9 or i=1, 3, 5, 7, 8 depending on the HD duration). All statistical analyses were performed 
using MATLAB version R2018b.
Results
In this study, ECG signals and [K+] from 29 ESRD-HD patients were investigated. An example of dw and d̂w,c time 
evolution for a particular patient, in PCA approach, was provided in Fig. 3. RR was represented on the x-axis in 
both panels, while dw and d̂w,c were shown on the y-axis in panel (a) and panel (b), respectively. The least-square 
fitting line (red line) was depicted in both panels. Spearman’s correlation coefficients ( ρ ) and p-values were also 
showed in each panel. High and significant correlation ( ρ = − 0.90 and p-value < 0.001 ) was found between 
RR and dw . However, after correcting for the HR-dependency, ρ = 0.03 and p-value = 0.76.
Correlation between [K+] and mean HR expressed in beats per minute (bpm) have also been computed and 
the results are presented in Table 2, with a Spearman’s correlation coefficient median (IQR) values of 0.10 (1.35), 
and a median p-value of p=0.33. These values were 0.09 (1.45), p = 0.22 for Pearson’s correlation coefficient.
Table 4 shows the intra-patient Spearman’s ( ρ ) and Pearson’s (r) correlation coefficients computed between the 
relative variations in [K+] (denoted as [K+] ) with respect to a reference [K+] that was taken at the end of the 
HD and the time-warping parameters. In both single-lead and PCA approaches, the highest median Spearman’s 
and Pearson’s correlation coefficients were found for duw , dw and dw,c being ρ ≥ 0.82 and r ≥ 0.86 for single-lead 
analysis and ρ ≥ 0.82 and r ≥ 0.89 in PCA.
Boxplots in Fig. 4 show the distributions of [K+] and the proposed PCA-based time-warping descriptors 
during HD. Figure 5b shows the average time evolution of PCA-based duw , dw , d̂w,c and dNLw  in the studied popula-
tion along the monitoring period, while the evolution of da and dNLa  is shown Fig. 5c.
Discussion
Repolarization abnormalities play a fundamental role in the genesis of arrhythmic events and the risk increases 
in patients at ESRD with imbalance in [K+]41. In this work, two previously reported potassium estimators, Tw
14 and TS/A15, four warping-based ECG-derived biomarkers for [K+] monitoring proposed in Ramírez et al.17, 
duw , da , dNLw  , dNLa  , and the here proposed modified versions dw and dw,c were tested as bloodless indices for [K+] 
variations in ESRD-HD patients computed from standard leads as well as in a PCA-derived lead. The most 
promising results in terms of correlation were obtained for markers duw , dw , and dw,c , leading to the highest 
median intra-patient ρ ≥ 0.82 and r ≥ 0.87 in single-lead and ρ ≥ 0.82 and r ≥ 0.89 in PCA lead respectively, 
evidencing high monotonic and linear association with [K+] and making them a promising non-invasive indices 
for blood [K+] monitoring.
The signed biomarker dw followed a similar time-course as the unsigned duw during the whole monitoring 
period, showing a similar distribution in Fig. 5a, as a result of the fact that the sign computed as in (5) is posi-
tive in roughly all the patients. That can be explained by the fact that the T-wave morphology in hyperkalemia 
is usually more peaked and shorter in time than a T-wave from regular [K+] concentrations, as happens at the 
end of HD, where the reference has been  taken42,43. Therefore, all the other MWTWs needed to be shrunk in 
amplitude and widened in time duration during the warping procedure to fit the reference one, and this is given 
by a positive signed dw . However, other external factors, such as the potassium removal  rates44 or the dialysate 
potassium  level45,46, might also have played a role in altering ventricular repolarization activity.
The warping algorithm is applied over the MWTWs computed from different observing windows with differ-
ent HRs, as is evident in Fig. 5a. Therefore, a corrected version of the dw , derived similarly to the QT correction 
 formula38,39, was proposed since the HR influences this marker as pointed out in Ramírez et al.17, and can be 
observed in Fig. 5a as an example around hours h = 9, 12 and 43. A large number of models have been proposed 
for the computation of QTc values independent of  HR37–40. However, a previous  study38 found that the linear 
regression model fits better than any other model to the relationship between QT and the RR intervals. Also, 
for small RR variations, in section “Heart-rate-corrected T-wave warping” it is shown that hyperbolic QT to 
RR dependency becomes linear. Therefore, we used a linear model to derive an HR-corrected index, dw,c . This 
approach was used to estimate the dw component strictly related to [K+] removing its relation with HR as showed 
in Fig. 3, where the HR-dependency, clearly visible in panel (a), was cancelled after the correction, panel (b). 
Comparing the results for duw , dw and d̂w,c , all of them have proved to be highly correlated with [K+] variations. 
However, it is important to remember that duw (and so dw ) is biased by the HR effects as previously  described17, 
while d̂w,c is no longer dependent on it, possibly being responsible for the lower IQR in the correlation, 0.25, 
as compared to 0.35 and 0.36 for dw and duw , respectively (see Table 4, PCA column). It should also be noted 
that the small differences between the ρ and r computed for d̂w,c and dw could be due to the low HR variations 
(23)�[K+](h) = ([K+]h − [K+]r)
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observed during HD, but larger HR variations, and consequently a higher impact of the correction, are expected 
in ambulatory monitoring.
In addition, we investigated the correlation between HR and [K+] finding no significant correlation between 
the two. To place these results into a proper context, in a previous study on computer-based models it was found 
that the heart rate in ESRD-HD patients is influenced by the combined effects of [K+] ), calcium and  pH47. In 
particular, it was observed that when [K+] is between 3 and 4 mmol/L, the HR sensitivity is about 10 bpm/mmol 
of [K+]47. As can be seen in Table 2, the median [K+] falls within the above mentioned range from h1 to h4 (i.e., 
almost during the entire HD session) but the range of HR variations is much bigger than the 10 bpm mentioned 
in Severi et al.47 (minimum IQR = 17 bpm at h3 ) so anticipating the obtained low and insignificant median 
correlations coefficients between HR and [K+] . This result suggests that HR variations are a poor indicator of 
Figure 4.  Boxplots showing the distribution of [K+] (blue) and all the described PCA-based time-warping 
biomarkers ( duw , da , dNLw  , dNLa  , dw , and d̂w,c ) (red), computed at different time points from the beginning, h0 , to 
the end, h4 , of the HD session ( h0 to h4 in Fig. 1). [K+] was computed as in (23). + denotes outliers.
Table 4.  Intra-patient Spearman’s ( ρ ) and Pearson’s (r) correlation coefficients between [K+] , and time-
warping based markers, and Tw and TS/A , in all cases evaluated from the first PCA transformed lead, and from 
standard single leads II, V3, V4, V5 and V6. Values are expressed as median (IQR).
Spearman’s ( ρ) Pearson’s (r)
PCA II V3 V4 V5 V6 PCA II V3 V4 V5 V6
duw
0.90
(0.37) 0.90 (0.40) 0.86 (0.50) 0.90 (0.38) 0.90 (0.25) 0.90 (0.29) 0.92 (0.36) 0.91 (0.37) 0.85 (0.37) 0.86 (0.41) 0.92 (0.14) 0.86 (0.30)
dw
0.82
(0.45) 0.90 (0.37) 0.90 (0.49) 0.90 (0.46) 0.90 (0.30) 0.90 (0.39) 0.89 (0.35) 0.90 (0.26) 0.88 (0.31) 0.86 (0.39) 0.93 (0.11) 0.87 (0.29)
d̂w,c
0.90
(0.31) 0.82 (0.28) 0.86 (0.40) 0.90 (0.50) 0.90 (0.30) 0.90 (0.38) 0.89 (0.25) 0.87 (0.33) 0.89 (0.29) 0.86 (0.49) 0.91 (0.17) 0.86 (0.27)
dNLw 0.82 (0.57) 0.43 (0.60) 0.70 (0.45) 0.67 (0.60) 0.70 (0.64) 0.80 (0.56) 0.68 (0.52) 0.47 (0.58) 0.61 (0.47) 0.56 (0.45) 0.56 (0.64) 0.61 (0.47)
da 0.21 (1.20) 0.00 (1.22) 0.50 (0.80) 0.40 (1.45) 0.45 (1.59) − 0.10 (1.15) 0.57 (1.53) 0.14 (1.55) 0.83 (0.67) 0.63 (1.71) 0.62 (1.65) − 0.32 (1.52)
dNLa 0.80 (0.42) 0.65 (0.70) 0.70 (0.59) 0.70 (0.77) 0.86 (0.45) 0.87 (0.40) 0.75 (0.39) 0.82 (0.83) 0.66 (0.56) 0.68 (0.84) 0.88 (0.30) 0.84 (0.38)
Tw − 0.70 (0.59) − 0.84 (0.57) − 0.90 (0.52) − 0.75 (0.67) − 0.80 (0.63) − 0.90 (0.65) − 0.92 (0.32) − 0.85 (0.35) − 0.87 (0.40) − 0.81 (0.62) − 0.84 (0.44) − 0.75 (0.48)
TS/A 0.80 (0.42) 0.62 (0.80) 0.60 (0.85) 0.46 (1.07) 0.76 (0.59) 0.63 (0.69) 0.86 (0.38) 0.83 (0.77) 0.71 (0.65) 0.46 (0.83) 0.74 (0.45) 0.72 (0.52)
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[K+] , at least in our dataset. Moreover, this finding gives validity to the proposal of the d̂w,c presented in this 
work, which assumes no correlation between HR and [K+]-related changes on T-wave morphology.
In a previous  study20 a comparison of Tw , TS/A , dw , dNLw  , da and dNLa  , based on a electrophysiological simula-
tion of ECG under hyperkalemia, was performed, and tested on a subset of the ESRD-HD patients described in 
Materials and Methods section. In that study it is shown that similar results were obtained in terms of Pearson’s 
correlation coefficient between [K+] and Tw , TS/A , and time-warping based markers, also showing a high cor-
relation with HR. In the present work we extended the analysis by increasing the sample size, introducing the 
proposed correction by HR, and comparing with single lead recordings. According to the Spearman’s ( ρ ) and 
Pearson’s (r) correlation coefficients, the median values are higher, and the IQR smaller, for duw , dw and dw,c than 
for TS/A using both PCA and standard single-lead approaches. For Tw , we found similar r median absolute values, 
as compared to duw,dw and dw,c , while Spearman’s correlation values were much lower for Tw when using PCA and 
several single-leads (e.g. lead V4 and V5). This shows that the proposed time-warping based markers present 
either higher correlation or stronger monotonic relationship with [K+] than Tw , and TS/A , making them more 
suitable for [K+] monitoring purposes.
When comparing single-lead and PCA-based analysis, and according to Spearman’s ( ρ ) and Pearson’s (r) 
correlation coefficients in Table 4, leads II, V3 and V5 are those showing the highest median and the smallest 
(a)
(b) (c)
Figure 5.  PCA-based time-warping markers and RR interval time trends. An example for a given patient 
undergoing 4h-long HD therapy, is depicted in panel (a) with the evolution of dw (filled green squares), d̂w,c 
(filled orange squares), both referring to the left vertical scale, and the average RR intervals (unfilled dark red 
squares, referring to the right vertical scale). [K+] relative variations with respect to the concentration at 
HD end (purple diamonds) are expressed in mmol/L. Time is expressed in hours from the beginning of the 
treatment onward. Each square denotes the mean RR interval in a 2-min wide segment used to compute the 
warping parameters, while the highlighted blue square corresponds to the reference segment at the end of HD. 
The filled red square denotes the time-point from which the studied MWTW in Fig. 2b was selected. Note that 
for this patient, the Holter recording did not reach the planned 48h. Panel (b) shows the median and IQR for 
each observing i-th segment, computed by using the values from all the available patients for duw , dw and d̂w,c 
and dNLw  (this latter refers to the right axis, while the others to the left). Time trends (expressed as median and 
IQR) for da and dNLa  , referring to the left and right axes respectively are in panel (c). Panels (b) and (c) give an 
overview of the time evolution for these biomarkers along the ECG acquisition from the HD beginning onward. 
Only the first 44 h were depicted being that the average ECG duration in our database.
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IQR values in a single-lead approach. Moreover, for da and dNLa  , leads V3 and V5 show stronger ρ and r correla-
tion with [K+] than the PCA lead, with ρ ≥ 0.45 and r ≥ 0.62 . However, median values for ρ and r computed 
between [K+] and duw , dw and dw,c , are similar ( ρ ≥ 0.82 and r ≥ 0.89 for the PCA lead and ρ ≥ 0.82 and 
r ≥ 0.86 for the standard single leads) showing no evident benefit in using one or the other strategy. Neverthe-
less, a clear advantage of extracting dNLw  from the PCA lead rather than from the standard single leads can be 
observed when comparing the medians both from ρ and r. In the same line, both Tw and TS/A showed higher r 
computed from the PCA lead than from standard leads. This improvement when analysing biomarkers estimated 
from specific local features of the T-wave, as Tw and TS/A , which is not that evident when analyzing global T-wave 
waveform based biomarkers, like those proposed in this work, can be explained by the improved SNR obtained 
by using PCA, leading to a more robust definition of the T-wave delineation marks. This is in agreement with 
several studies reporting the benefits of PCA as an intermediate step when addressing problems related with 
noise  reduction28. Therefore, the use of PCA from multilead ECG is recommended as a more robust alternative 
to single-lead analysis.
As already described, ECGs recorded under hyperkalemic conditions commonly present T-waves which are 
taller than those for normal levels of blood [K+] . The marker da was designed to capture the amplitude variabil-
ity between f i(ti) and f r(tr) after warping. However, from its original definition, da can take both positive and 
negative values, producing positive intra-patient ρ and r between [K+] and da in 62% of the cases and negative 
in 38% of the cases. This explains the low median inter-patient correlation ( ρ = 0.21 ) and the wide IQR (1.20). 
However, if its absolute value was considered then correlation between [K+] and da becomes larger being 
ρ = 0.70 (0.60) and r = 0.75 (0.31).
Cellular AP duration can be affected in a heterogeneous manner by [K+] fluctuations since ion channel expres-
sion is heterogeneous throughout the  ventricles48 and this can result in non-linear changes on T-wave morphol-
ogy. According to their  definition17, dNLw  and dNLa  were designed to quantify the inhomogeneous morphological 
variations during ventricular repolarization; this fact might explain their correlation with [K+] . Both of them 
showed a remarkable sensitivity to the variations of ventricular spatio-temporal dispersion independently from 
changes in  HR17, meaning that they did not need a HR correction as was done for dw . This last point, particularly 
for dNLa  , in addition to its also high correlation with [K+] , make it an interesting T-wave descriptor for blood 
[K+] assessment.
Results of the present work, show high accuracy of the dw dw,c T-wave based time-warping biomarkers for [K+] 
monitoring, in contrast with the findings in a recent study published by Regolisti et al.49 where lower correlation 
values were reported for other ECG-derived markers. The explanation for this discrepancy could be tracked back 
to the biomarkers the authors took as reference for their research, from Dillon et al.13 and Corsi et al.15, which 
are a) focused on specific features of the T-waves and b) measured in absolute value and not in relative terms 
to a reference which can personalize the biomarker as here presented. Nevertheless, time warping analysis was 
applied in recent  studies19, 20 to investigate both hypo- and hyperkalemia on a extremely heterogeneous pool of 
simulated cases, performing equally well in all the cases and proving its adaptability, at least in silico simulated 
ECGs, probably due to its personalize profile as being comparative with a reference. Therefore, we hypothesized 
that the proposed methodology for [K+] monitoring could be applied to investigate a wide range of populations 
and experimental sets.
Other recent studies developed deep-learning models and tested them on large datasets to screen for hyper-
kalemia in patients with CKD, reporting a more robust recognition of severe hyperkalemia, thus potentially 
reducing the risk of sudden cardiac death in those  patients50,51. However, in our study we aim, not just to detect 
hyperkalemia, but also in continuous [K+] quantification. Extension of the database will open the door to use 
deep learning techniques, which will allow proper comparison with the methodology here proposed.
The main limitation of this work concerns the reduced amount of blood tests (only six) took from each patient 
during the 48-h ECG recording, which provided an accurate representation of the [K+] time evolution only 
during HD, but not during the ambulatory period. On this basis, it was possible to investigate the relationship 
between the proposed markers and the [K+] only during the therapy but not through the remaining hours. 
Moreover, the course of HD procedures can be accompanied by  ischaemia52–54, which can also be associated 
with changes in the T-wave, independently from HR, therefore reflected on dw,c . Elucidation of its impact in 
monitoring normal-life outside the HD process needs to be explored in a dedicated study. Also postural or body 
position changes (BPC) are known to affect the T-wave morphology and mainly the T-wave  amplitude55, which 
can influence da related biomarkers. The fact that those markers were measured on PCA lead could attenuate the 
effect of BPC on T-wave, however a specific study should precisely establish the impact of this aspect on the bio-
marker, particularly when applied in a non controlled scenario. Assessment of the performance of the proposed 
descriptors in patients with hypokalemia remains to be studied. In addition, the methodology proposed in this 
work needs to be validated in: (a) a larger population; and (b) subsequent HD sessions on the same population, 
which would allow to quantify the accuracy in [K+] estimation.
Beyond the previous considerations, dw , d̂w,c and dNLa  showed potential value in monitoring changes in blood 
potassium concentration. All of them showed a time-course similar to that of [K+] in ESRD-HD patients as 
described in  literature45,46: a rapid decline during the HD with a fast rebound just after the end of the therapy, 
followed by a steady increase in the remaining hours before the next HD session (see Fig. 5b,c). Therefore, it is 
possible to consider the biomarkers use for continuous [K+] monitoring, also in other pathologies as in patients 
suffering heart  failure56, where hyperkalemia also increases the risk for SCD.
As a future study, we propose to replicate the same analysis over a larger population and assess the correlation 
between the proposed time-warping markers and alterations in other electrolytes beyond [K+] , like calcium, 
magnesium, or related to the rate and amount of [K+]  removal44–46. These variations could alter the ECG and it 
would be interesting to analyse their relationship with the induced T-wave changes. Then, as mentioned above, 
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there is a need to test the proposed indices and investigate their robustness against these possible confounders. 
Other alternatives for lead space reduction, such as Periodic Component  Analysis57, can be explored to check 
whether the T-wave shape is better emphasized with a criterion different from just the energy maximisation 
considered by PCA. A study to test the extrapolation power of the current findings, which refer to [K+] levels at 
h4 , to subsequent HD sessions should also be performed to assess their clinical long-term validity.
Conclusions
In this study, time-warping markers ( dw , da ), their non linear components ( dNLw  and dNLa  ) and a HR-corrected 
version dw,c , in all cases personalised making it relative to reference point, were studied in ESRD patients under-
going HD and evaluated as estimator of [K+] changes over time. Among the analyzed biomarkers and methods 
(i.e. standard single-lead or PCA transformed lead approaches), the proposed PCA-based dw and its HR cor-
rected version, dw,c , achieved better results than the previously proposed TS/A in terms of both Spearman’s and 
Pearson’s correlation with [K+] , and showed higher monotonic relationship than Tw , thus making the proposed 
time-warping markers a valid and more accurate alternative to the currently available tools for [K+] ambula-
tory monitoring of ESRD-HD patients. In conclusion, this study proposes new markers for robust quantitative 
ambulatory monitoring of [K+] from the ECG. The proposed markers could improve routine [K+] monitoring 
without the need of invasive blood test, both in hospital and in an ambulatory scenario. A comprehensive valida-
tion is needed to corroborate the extrapolation power of these results.
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